-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Tenaya Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q3 2024.
- Tenaya Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $1.08M, a 39.4% decline year-over-year.
- Tenaya Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $5.51M, a 16.9% decline year-over-year.
- Tenaya Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $7.11M, a 263% increase from 2022.
- Tenaya Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $1.96M, a 2201% increase from 2021.
- Tenaya Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $85K, a 83.6% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)